AI 3-19500

• CAT Number: I021614
• CAS Number: 523-42-2
• Molecular Formula: C29H35IN2
• Molecular Weight: 538.52
• Purity: 98%
• Synonyms: AI 3-19500; AI-3-19500; Al3-19500
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (4E)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide
• InChI: InChI=1S/C29H35N2.HI/c1-22(2)13-17-30-19-15-24(26-9-5-7-11-28(26)30)21-25-16-20-31(18-14-23(3)4)29-12-8-6-10-27(25)29;/h5-12,15-16,19-23H,13-14,17-18H2,1-4H3;1H/q+1;/p-1
• InChIKey: QGKMIGUHVLGJBR-UHFFFAOYSA-M
• SMILES: CC(C)CCN1C=C/C(=C\C2=CC=[N+](C3=CC=CC=C23)CCC(C)C)/C4=CC=CC=C41.[I-]

AI 3-19500（Cat No.:I021614）is an experimental small molecule that has been studied for its potential therapeutic applications in oncology. It is believed to target specific cellular pathways involved in tumor growth, metastasis, and resistance to chemotherapy. While detailed information on the compound’s mechanism of action is still under investigation, AI 3-19500 is being evaluated for its ability to interfere with cancer cell proliferation and enhance the efficacy of other cancer treatments. As of now, it remains in the early stages of preclinical or clinical research, with more studies required to determine its safety and effectiveness in humans.